Trials / Completed
CompletedNCT06499571
Geographic Atrophy Long-Terms Outcomes Study
G.A.L.T.O.S. Geographic Atrophy Long-Terms Outcomes Study: An Ambispective Noninterventional Study to Describe the Patient Demographics and Outcomes of Patients With Geographic Atrophy (GA) Secondary to AMD in Clinical Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 255 (actual)
- Sponsor
- Apellis Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to describe functional and long-term clinical outcomes of patients with a diagnosis of Geographic Athrophy secondary to Age related Macular Degenaration in Clinical Practice
Conditions
Timeline
- Start date
- 2022-09-01
- Primary completion
- 2023-07-31
- Completion
- 2023-07-31
- First posted
- 2024-07-12
- Last updated
- 2024-07-12
Locations
5 sites across 5 countries: Australia, France, Germany, Italy, United Kingdom
Source: ClinicalTrials.gov record NCT06499571. Inclusion in this directory is not an endorsement.